FM Sánchez-Vargas, OG Gómez-Duarte - Clinical microbiology and …, 2008 - Elsevier
Mycoplasma is a well-recognised pathogen that colonises mucosal surfaces of humans and animals. Mycoplasma pneumoniae infects the upper and lower respiratory tracts of children …
Background M. pneumoniae pneumonia (MP) has been reported in 10-40% of community- acquired pneumonia cases. We aimed to evaluate the difference of clinical features in …
Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, which is often empirically treated with macrolides or azalides such as erythromycin or azithromycin …
S Dégrange, C Cazanave, A Charron… - Journal of clinical …, 2009 - Am Soc Microbiol
In this study we report on the development of a multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) method for the molecular typing of Mycoplasma pneumoniae. The …
JM Winchell, KA Thurman, SL Mitchell… - Journal of clinical …, 2008 - Am Soc Microbiol
We compared the performances of three recently optimized real-time PCR assays derived from distinct genomic regions of Mycoplasma pneumoniae during an outbreak …
KA Thurman, AK Warner, KC Cowart, AJ Benitez… - … and infectious disease, 2011 - Elsevier
A multiplex real-time PCR assay for the detection of Mycoplasma pneumoniae (MP181), Chlamydia (Chlamydophila) pneumoniae (CP-Arg), Legionella spp.(Pan-Leg), and the …
AC Nilsson, P Björkman, C Welinder-Olsson… - BMC infectious …, 2010 - Springer
Abstract Background Disease severity in Mycoplasma pneumoniae (MP) infection could potentially be related to bacterial factors such as MP genotype (MP1 or MP2; distinguished …
Particle exposures increase the risk for human infections. Particles can deposit in the nose, pharynx, larynx, trachea, bronchi, and distal lung and, accordingly, the respiratory tract is the …
We searched PubMed for peer-reviewed literature over the past 3 decades with a focus on studies that reported data on the associations among tuberculosis, smoking, HIV, influenza …